Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPI and Narcotrend-Guided TIVA in Obstetrics and Gynecology ERAS
ChiCTR2200062284Phase 4Not yet recruiting
- Sponsor
- International Peace Maternity and Child Health Hospital
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol in gynaecological conditions (2 arms), sponsored by International Peace Maternity and Child Health Hospital. Primary endpoints: Surgical Pleth Index (SPI), Anesthesia depth and 1 more. Planned start Aug 2022; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
gynaecological conditions
Beyond the preview
Go deeper on ChiCTR2200062284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200062284.